UCL Technology Fund Investor
UCL TF is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base
Technology:
Cell_Therapies, DeepTech
Industry:
Longevity Industry 2022
Headquarters:
London, England, United Kingdom
Founded Date:
2016-01-01
Employees Number:
10001+
Funding Status:
Private
Investor Type:
Venture Capital
Number Of Exits:
5
Investors Number:
26
Estimated Revenue:
Less than $1M
Register and Claim Ownership